Orchard Therapeutics (Europe) Limited – Trademark Portfolio
Entity Type: 99
Orchard Therapeutics (Europe) Limited holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 12 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 4 trademarks are registered and 1 is pending. Notable registered marks include OLADAH, J-BOOST, LENMELDY, and LIBMELDY.
108 Cannon Street
London EC4N 6EU
Showing of trademarks Trademarks
Trademark Classifications
Orchard Therapeutics (Europe) Limited's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Orchard Therapeutics (Europe) Limited have?
Orchard Therapeutics (Europe) Limited has 12 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 pending, 6 cancelled.
What trademark classes does Orchard Therapeutics (Europe) Limited file in?
Orchard Therapeutics (Europe) Limited files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Orchard Therapeutics (Europe) Limited's most well-known trademarks?
Orchard Therapeutics (Europe) Limited's registered trademark portfolio includes well-known marks such as OLADAH, J-BOOST, LENMELDY, and LIBMELDY. These are among 4 currently registered trademarks in the portfolio.
What is Orchard Therapeutics (Europe) Limited's trademark registration success rate?
Orchard Therapeutics (Europe) Limited has a 40% trademark registration rate, with 4 out of 10 resolved applications resulting in successful registration. Currently, 1 application is pending review.